BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

IOMAI Corporation 

20 Firstfield Road, Suite 250

Gaithersburg  Maryland  20878  U.S.A.
Phone: 301-556-4500 Fax: 301-556-4501


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Intercell AG Buys IOMAI Corporation (IOMI) for $189 Million 8/6/2008 7:36:24 AM
IOMAI Corporation (IOMI) Stockholders Approve Merger With Intercell AG Subsidiary 8/1/2008 7:37:58 AM
IOMAI Corporation (IOMI) Likely to Sell to Intercell AG Sooner than Expected 7/14/2008 7:41:53 AM
IOMAI Corporation (IOMI) Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers' Diarrhea Vaccine 6/12/2008 9:03:57 AM
IOMAI Corporation (IOMI) to Host Conference Call and Webcast Tomorrow, Tuesday, May 13, at 8:30 a.m. EDT 5/14/2008 8:13:20 AM
Intercell AG to Acquire IOMAI Corporation (IOMI) to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation for About $189M 5/13/2008 7:09:41 AM
IOMAI Corporation (IOMI) Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4/16/2008 7:42:40 AM
IOMAI Corporation (IOMI) Receives Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch 4/15/2008 8:40:06 AM
IOMAI Corporation (IOMI) Wins Department of Defense Grant to Develop a Stable, Patch-Based Anthrax Vaccine 4/8/2008 10:07:44 AM
IOMAI Corporation (IOMI) and Merck & Co., Inc. (MRK) Evaluate Use of Iomai Immunostimulant Patch 4/3/2008 7:53:02 AM
1234567